Table 3 Multivariate Cox-regression analysis of the prognostic impact on metachronous distant metastasis
From: Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer
| Â | p | HR | 95% CI | |
|---|---|---|---|---|
Lower | Upper | |||
KRAS (mutated) | 0.008 | 3.21 | 1.36 | 7.59 |
BRAF (mutated) | 0.106 | 5.45 | 0.67 | 42.42 |
MMR (MSI-H) | 0.777 | 0.81 | 0.19 | 3.50 |
Osteopontin (continuously) | 0.852 | 1.00 | 0.99 | 1.00 |
SASH1 (continuously) | 0.103 | 3.01 | 0.80 | 11.31 |
MACC1 (continuously) | 0.980 | 0.99 | 0.90 | 1.11 |
CD3 (continuously) | 0.109 | 1.01 | 0.99 | 1.01 |
CD8 (continuously) | 0.009 | 0.99 | 0.97 | 0.99 |